Shares of Nano-X Imaging Ltd. (NNOX) gained over 5% on Thursday morning after the company's Nanox.ARC received additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications.
NNOX is currently trading at $6.63, up $0.35 or 5.57%, on the Nasdaq. The stock opened its trading at $7.10 after closing Wednesday at $6.28. The stock has traded between $5.26 and $14.28 in the past 52-week period.
NANO-X IMAGING, a medical imaging technology company, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Nanox.ARC, a stationary X-ray system intended to produce tomographic images for general use including human musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications, adjunctive to conventional radiography, on adult patients.
"With this FDA clearance, we can now offer U.S. healthcare providers significantly broader imaging capabilities that are akin to commonly used traditional X-ray devices," said Erez Meltzer, Nanox Chief Executive Officer and Acting Chairman. "Our mission is to provide healthcare practices with a transformative imaging advantage with the Nanox.ARC - an accessible, cost-effective solution that not only provides advanced diagnostic imaging capabilities but also elevates overall patient care. We look forward to bringing this technology to more healthcare facilities throughout the country."
For comments and feedback: editorial@rttnews.com